[
    {
        "utterance": "Linnea Freeman- Furman University: That's what we did in the last group, but we kind of made a mistake in the last, like yesterday's group because our four reporter also or recorder was also our reporter because we ",
        "annotations": {
            "express frustration": "The speaker expresses frustration by mentioning a mistake made in the previous group meeting, indicating dissatisfaction with how things were handled."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Yeah, same with me. I didn't write anything yet, but I can do that. ",
        "annotations": [
            {
                "express agreement": "Leah agrees with Linnea's previous statement about a similar situation occurring in their group.",
                "assign task": "Leah volunteers to take on the task of writing, which implies she is assigning the task to herself."
            }
        ]
    },
    {
        "utterance": "Linnea Freeman- Furman University: Okay. Um, I'm jotting notes too, like um next to me just to Okay. I just want to collaborate from bullet points. ",
        "annotations": {
            "assign task": "Linnea is assigning herself the task of jotting down notes, indicating a division of labor within the group.",
            "explain or define term or concept": "Linnea is clarifying that she wants to collaborate using bullet points, explaining her preferred method of collaboration."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Do you want me to recap for you what the question was first or you you going to tell people that specific everyone else won't know these prompts. ",
        "annotations": {
            "ask clarifying question": "Leah is asking Linnea if she wants her to recap the question first, to ensure everyone understands the prompts, which is a request for clarification."
        }
    },
    {
        "utterance": "Linnea Freeman- Furman University: Um, I can I can like quickly say them, but I noticed there's two groups that are doing neuroinflammation. Kind of like yesterday I was in everyone was doubled up, so I don't remember if we're going first or second for that. ",
        "annotations": {
            "explain or define term or concept": "The speaker is clarifying that two groups are working on neuroinflammation, which is relevant to the discussion.",
            "ask clarifying question": "The speaker is asking whether their group is going first or second, seeking clarification on the order of presentations."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Okay. I think we're room three, so I'll just put it in the three one. All right, so I guess I read my notes, but what what do you want me to put as our actual notes for the point one. ",
        "annotations": [
            {
                "acknowledge contribution": "The speaker says 'Okay' to acknowledge the previous speaker's contribution.",
                "propose decision": "The speaker proposes a decision to put the notes in the 'three one' location, indicating room three."
            },
            {
                "ask clarifying question": "The speaker asks what notes the other person wants them to put for point one, seeking clarification on the content of the notes."
            }
        ]
    },
    {
        "utterance": "Ashley Ross-Univ. of Cincinnati: Can I just add something as a highly highly biased analytical chemist? Um, I think all of these questions almost begs the need for new technologies to be able to answer these questions, which is something we didn't necessarily talk about, but I mean, a lot of these questions, I think to really truly answer them, we need new techniques to be able to make these measurements. ",
        "annotations": {
            "present new idea": "The speaker introduces the idea that new technologies are needed to answer the research questions, which hasn't been explicitly discussed before.",
            "provide supporting evidence": "The speaker, identifying as an analytical chemist, suggests that the nature of the questions implies a need for new technologies to make the necessary measurements, supporting the idea with their expertise.",
            "expand on existing idea": "The speaker expands on the discussion by suggesting that new technologies are needed to answer the research questions, adding a new dimension to the conversation."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: I think that's always true. Uh yeah, so so what would you what would you like what's low hanging fruit actually? Like what is like the most obvious one or two you know, currently unavailable technologies to sort of address neuroimmune interactions. ",
        "annotations": [
            {
                "express agreement": "The phrase \"I think that's always true\" expresses agreement with Ashley's prior statement that new technologies are needed to answer the questions.",
                "ask clarifying question": "The question \"what's low hanging fruit actually? Like what is like the most obvious one or two you know, currently unavailable technologies to sort of address neuroimmune interactions\" asks for specific examples of technologies that could address neuroimmune interactions, building on the previous discussion about the need for new technologies."
            }
        ]
    },
    {
        "utterance": "Ashley Ross-Univ. of Cincinnati: Well, I mean, this again is my biased approach. We talked a lot about cytokine signaling, but right now the best cytokine assays are Eliza's that take hours. But wouldn't it be nice to be able to measure proteins in a much rapid time scale. ",
        "annotations": {
            "provide supporting evidence": "The speaker supports their claim about the need for new technologies by stating that current cytokine assays like Eliza's take hours, implying a need for faster measurement techniques, building on the previous turn where she mentioned the need for new technologies.",
            "present new idea": "The speaker introduces the idea of measuring proteins in a much more rapid time scale, which is a novel concept not previously discussed in the context of addressing the limitations of current cytokine assays."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: You know, there all these like there are these like dopamine sensors that have come out, right? You really dynamic, you know, there's a serotonin sensor that I think was just published, right? So something along those lines of using maybe fluorescent reporters uh that's that emits signals in in really in milliseconds, right? ",
        "annotations": {
            "expand on existing idea": "Sarkis is expanding on Ashley's idea of needing new technologies to measure cytokine signaling by providing examples of dopamine and serotonin sensors as potential solutions.",
            "provide supporting evidence": "Sarkis mentions the existence of dopamine and serotonin sensors, including a recently published serotonin sensor, to support the feasibility of developing new technologies for measuring neuroimmune interactions.",
            "explain or define term or concept": "Sarkis explains the concept of using fluorescent reporters that emit signals in milliseconds as a potential technology for measuring neuroimmune interactions."
        }
    },
    {
        "utterance": "Ashley Ross-Univ. of Cincinnati: Because it's not really as far as I'm as far as my understanding, it's not really understood what the temporal scale of cytokine signaling is because no one can really measure it. ",
        "annotations": {
            "provide supporting evidence": "The speaker is providing evidence for the need for new technologies by stating that the temporal scale of cytokine signaling is not well understood because current measurement techniques are inadequate, supporting her earlier claim about the need for new technologies.",
            "expand on existing idea": "This utterance expands on the previously mentioned idea of needing new technologies to answer questions about cytokine signaling by explaining why current technologies are insufficient."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: There are there are some technologies that are more much more sensitive than than Eliza's or bioflex now, right? Like Samoa and and others. Um, but they don't get to your question or your point which is which is important as well. So part of it is sensitivity, part of it is like is is, you know, the temporal aspect of this, right? And and and knowing when and where certain cytokines are, you know, so now I'm thinking more broadly because again of these ",
        "annotations": [
            {
                "provide supporting evidence": "Sarkis mentions technologies like Samoa that are more sensitive than Eliza's or bioflex, providing evidence to support the need for better measurement techniques, which was brought up by Ashley in the previous turn.",
                "acknowledge contribution": "Sarkis acknowledges Ashley's point about the limitations of current technologies for measuring cytokine signaling, recognizing the importance of her contribution to the discussion.",
                "expand on existing idea": "Sarkis expands on Ashley's idea about the need for new technologies by discussing sensitivity and the temporal aspect of cytokine signaling, building upon the previous discussion about limitations of current cytokine assays."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Yeah. ",
        "annotations": [
            {
                "express agreement": "Sarkis agrees with Ashley's point about the need for new technologies to measure cytokine signaling on a rapid time scale."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: you know, of these you know, of these new um neurotransmitter reporters, right? That wouldn't it be cool to look at a tissue and see all, you know, multiple cytokines and multiple neurotransmitters going up and down in real time, right? ",
        "annotations": [
            {
                "present new idea": "Sarkis introduces the novel concept of using neurotransmitter reporters to observe multiple cytokines and neurotransmitters in real-time within a tissue, which hasn't been explicitly discussed before."
            },
            {
                "express enthusiasm": "Sarkis expresses enthusiasm for the idea of observing multiple cytokines and neurotransmitters in real-time by asking rhetorically if it wouldn't be cool to do so."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Um and so I think, you know, being able to to and I don't know if these these I suspect that they're they're you know, that that like the dopamine like D light actually gets into a synapse, right? I I suspect it must, right? For it to to actually measure the ",
        "annotations": [
            {
                "expand on existing idea": "Sarkis is expanding on the idea of using fluorescent reporters for neurotransmitters, building on Ashley's suggestion for new technologies to measure cytokines by considering dopamine sensors."
            },
            {
                "ask clarifying question": "Sarkis is asking a clarifying question about whether dopamine sensors like D light can actually get into a synapse, seeking to confirm their functionality."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: relevant dopamine that's being released. Um and so if we can get those those types of sensors for cytokines and and neurotransmitters and multiplex system in a tissue and I think that would be ",
        "annotations": {
            "expand on existing idea": "The speaker is building on the previous discussion about dopamine sensors and suggesting a similar approach for cytokines and neurotransmitters, expanding on the idea of using sensors for real-time measurements.",
            "express enthusiasm": "The speaker expresses excitement about the possibility of using sensors for cytokines and neurotransmitters in a multiplex system, indicating enthusiasm for the potential of this approach."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Yeah. ",
        "annotations": {
            "express agreement": "Sarkis agrees with Ashley's point about the need for new technologies to answer questions about cytokine signaling, as well as the limitations of current technologies like Eliza's."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): I put some notes up here. ",
        "annotations": {
            "acknowledge contribution": "Leah is indicating that she has added notes, acknowledging her own contribution to the discussion."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): I'm not sure we got to the third point, but let me know what you want me to add or take away. ",
        "annotations": {
            "encourage participation": "Leah is inviting others to contribute by asking them to provide feedback on what she should add or remove from her notes, which she just shared with the group."
        }
    },
    {
        "utterance": "Noah Palm - Yale: And we've been working on these multiplex developing, we haven't published any of them yet, but developing these ultra high throughput multiplexed um GPCR screening assays where we can use barcoding and next gen sequencing to deconvolve um hundreds of receptors in a single well. ",
        "annotations": {
            "present new idea": "Noah introduces the novel concept of ultra-high throughput multiplexed GPCR screening assays using barcoding and next-gen sequencing, which hasn't been previously discussed.",
            "expand on existing idea": "Noah expands on the need for new technologies to answer questions by describing the development of ultra high throughput multiplexed GPCR screening assays, building upon Ashley's suggestion for new technologies."
        }
    },
    {
        "utterance": "Noah Palm - Yale: Um, and my dream has been to your point, circus. I haven't figured out how to do it yet, but to figure out how to implement this in vivo so that you'd be able to, you know, simultaneously interrogate the activities of all say G protein coupled receptors at the same time. ",
        "annotations": [
            {
                "expand on existing idea": "Noah is building on Sarkis's idea of using sensors to measure neurotransmitters and cytokines in real-time, expressing his desire to implement a similar approach for GPCRs in vivo."
            },
            {
                "present new idea": "Noah introduces the idea of using ultra-high throughput multiplexed GPCR screening assays with barcoding and next-gen sequencing to interrogate the activities of G protein-coupled receptors simultaneously."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: You know, what about using some like spatial genomics, right? Where where you now get ",
        "annotations": [
            {
                "present new idea": "Sarkis introduces a new idea of using spatial genomics, which hasn't been discussed before in the context of addressing neuroimmune interactions."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: you can essentially do, you know, gene expression, you can do transcriptomics but in fixed tissue, right? So you know where when you know, not just when but where the cells in the fix. But you know, which cells are are are, you know, producing, you know, the transcripts of interest. ",
        "annotations": [
            {
                "explain or define term or concept": "Sarkis is explaining spatial genomics, which involves gene expression and transcriptomics in fixed tissue, allowing the identification of which cells are producing transcripts of interest, building on the previous discussion about measuring cytokines and neurotransmitters in real-time."
            },
            {
                "expand on existing idea": "Sarkis is expanding on the idea of using spatial genomics to understand gene expression and transcriptomics in fixed tissue, building on the previous discussion about measuring cytokines and neurotransmitters in real-time."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Leah Pyter OSU (she/her) has started screen sharing ",
        "annotations": {
            "acknowledge contribution": "The utterance acknowledges Leah Pyter's action of starting screen sharing, without expressing agreement or expanding on it."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: I think that would be that's that's that's a needed technology. ",
        "annotations": {
            "express agreement": "Sarkis expresses agreement with the need for new technologies to answer the questions, building on Ashley's point about the need for new technologies and his own exploration of dopamine and serotonin sensors."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): I put some notes up here. I'm not sure we got to the third point, but let me know what you want me to add or take away. ",
        "annotations": {
            "acknowledge contribution": "Leah acknowledges that she has added notes, recognizing her own contribution to the discussion.",
            "ask clarifying question": "Leah asks for feedback on her notes, specifically requesting what to add or remove, seeking clarification and guidance from the group."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: The third point was how do we study it effectively? ",
        "annotations": {
            "explain or define term or concept": "Sarkis is clarifying the third point of discussion, which is about effective study methods, in response to Leah's uncertainty about whether they covered it."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): That what you're referring to? Um, no, the third wasn't there a third question? Do we really understand the ",
        "annotations": {
            "ask clarifying question": "Leah asks if there was a third question, seeking clarification on the prompts."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): organization structures and functions of the inter system. I think we probably agree that we don't really completely understand any of those. ",
        "annotations": [
            {
                "express agreement": "Leah expresses agreement that they don't completely understand the organization structures and functions of the inter system, building on the previous discussion about the third point."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Yeah, I'm not sure the answer is binary. Uh but uh you know, I I think it's safe to say that that there's tantalizing uh you know, tidbits of evidence but clearly don't don't understand. ",
        "annotations": [
            {
                "express agreement": "Sarkis agrees with the previous statement that they don't completely understand the organization structures and functions of the inter system."
            }
        ]
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: You know, in my I mean, in the absence of knowing we don't know, but I suspect there's a lot of interactions that we just simply have not measured yet. ",
        "annotations": {
            "expand on existing idea": "Sarkis is expanding on the previous discussion about the limitations in current technologies for measuring neuroimmune interactions, suggesting that there are likely many interactions that haven't been measured yet, building upon the idea that current methods are insufficient.",
            "present new idea": "Sarkis is presenting the idea that there are many interactions that we have not measured yet, which is a novel concept in the context of the discussion about limitations in current technologies."
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Um that's is this help Linnea? ",
        "annotations": {
            "ask clarifying question": "Leah is asking Linnea if the notes she provided are helpful, seeking confirmation that her contribution is meeting Linnea's needs."
        }
    },
    {
        "utterance": "Linnea Freeman- Furman University: Yeah, I was just jotting down like I was trying to write what you guys were saying. ",
        "annotations": {
            "acknowledge contribution": "Linnea acknowledges that she was writing down what Leah and Sarkis were saying, recognizing their contribution to the discussion."
        }
    },
    {
        "utterance": "Linnea Freeman- Furman University: Um this is good. I can elaborate on some of these points. You don't have to write everything down. That's why I was frantically writing. ",
        "annotations": [
            {
                "acknowledge contribution": "Linnea acknowledges Leah's notes by saying \"this is good\", recognizing her input without necessarily agreeing or expanding on it.",
                "expand on existing idea": "Linnea offers to elaborate on the points already made, building on the existing ideas discussed.",
                "assign task": "Linnea tells Leah that she doesn't have to write everything down, implicitly relieving her of the task of comprehensive note-taking."
            }
        ]
    },
    {
        "utterance": "Linnea Freeman- Furman University: I won't talk too long either. ",
        "annotations": {
            "express agreement": "Linnea assures the group that she will be brief, implicitly agreeing to keep the discussion concise and efficient, which aligns with the group's need to cover multiple points."
        }
    },
    {
        "utterance": "Linnea Freeman- Furman University: I'll try not to. ",
        "annotations": {
            "express humor": "The speaker is making a self-deprecating joke about talking too much, following up on her previous statements about elaborating on points and not talking too long."
        }
    },
    {
        "utterance": "Noah Palm - Yale: Yeah, basically deposits a label, a biotin label on neighboring cells, right? So it's kind of like an in vivo ",
        "annotations": [
            {
                "explain or define term or concept": "The speaker is explaining the mechanism of a technology by describing how it deposits a biotin label on neighboring cells."
            }
        ]
    },
    {
        "utterance": "Noah Palm - Yale: So what you're saying is nothing's ever going to be better than sort taste. ",
        "annotations": {
            "express humor": "The speaker is making a joke, implying that a sophisticated technology might not surpass a simple method like taste, likely in response to the discussion about advanced measurement techniques."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: It's inconceivable, right? ",
        "annotations": {
            "express humor": "Sarkis makes a humorous statement, implying that something will never be better than a certain standard, which is likely intended as a joke given the preceding discussion about technologies."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: It's inconceivable, right? ",
        "annotations": [
            {
                "express humor": "Sarkis is making a joke, building on Noah's comment about nothing being better than sortase, by saying it's inconceivable, which is humorous in this context."
            }
        ]
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Anything else we want to add? ",
        "annotations": {
            "encourage participation": "Leah is asking if anyone has anything else to contribute to the discussion, encouraging participation from the group."
        }
    },
    {
        "utterance": "Linnea Freeman- Furman University: I will be honest. ",
        "annotations": {
            "None": "This utterance does not contain any information that can be categorized by the codebook."
        }
    },
    {
        "utterance": "Linnea Freeman- Furman University: I don't know what the lipstick model is. ",
        "annotations": {
            "ask clarifying question": "Linnea asks for clarification about the 'lipstick model', indicating she doesn't understand the term, which is a request for explanation."
        }
    },
    {
        "utterance": "Noah Palm - Yale: though proximity labeling kind of approach. ",
        "annotations": {
            "expand on existing idea": "Noah Palm is expanding on the idea of proximity labeling, which was mentioned in the previous utterance, by describing it as a 'kind of' approach."
        }
    },
    {
        "utterance": "Linnea Freeman - Furman University: Okay, cool. ",
        "annotations": {
            "express agreement": "Linnea expresses agreement with the preceding discussion about proximity labeling, indicated by her saying \"Okay, cool.\""
        }
    },
    {
        "utterance": "Noah Palm - Yale: Is that a good way to describe someone probably on here knows it better than I do, but. ",
        "annotations": {
            "encourage participation": "Noah is asking if his description of proximity labeling is accurate, encouraging someone with more expertise to contribute."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Yeah, no, I think this captures, this captures most of of what we discussed. And again, you know, I think the topic itself, like many other topics, the topic itself is is one that that's, you know, ",
        "annotations": {
            "express agreement": "Sarkis agrees that the notes Leah put up captures most of what they discussed, indicating agreement with the summary of their conversation.",
            "acknowledge contribution": "Sarkis acknowledges that the notes capture most of what they discussed, recognizing Leah's contribution of summarizing the discussion."
        }
    },
    {
        "utterance": "Sarkis Mazmanian - Caltech: Hey, are we are we happy with our with our report? Is we can break out, we can break out, we can leave the breakout room. ",
        "annotations": {
            "propose decision": "Sarkis is suggesting a concrete choice for the group, which is to end the breakout session and leave the room, contingent on satisfaction with the report."
        }
    },
    {
        "utterance": "Linnea Freeman - Furman University: Thanks, Leah. ",
        "annotations": {
            "acknowledge contribution": "Linnea acknowledges Leah's contribution to the discussion, expressing gratitude for her input."
        }
    },
    {
        "utterance": "Noah Palm - Yale: Nice chatting with you all. ",
        "annotations": {
            "express enthusiasm": "Noah expresses a positive sentiment about the conversation, indicating enjoyment of the discussion with the group."
        }
    }
]